Physiology of Erectile Function: An Update on Intracellular Molecular Processes{A figure is presented}

EAU-EBU Update Series

Volumn 4, Issue 3-4, 2006, Pages 96-108

  Morelli, Annamaria ^a   Filippi, Sandra ^a   Vignozzi, Linda ^a   Mancina, Rosa ^a   Maggi, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Androgens; Erectile dysfunction; Erectile function; NO cGMP signalling; PDE5; Penile smooth muscle tone; RhoA ROK pathway

Indexed keywords

ANDROGEN; CALCIUM; CYCLIC GMP; NEUROTRANSMITTER; NITRIC OXIDE; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; RHO KINASE;

ARTICLE; CALCIUM CELL LEVEL; CORPUS CAVERNOSUM; DRUG TARGETING; ERECTILE DYSFUNCTION; GENE TARGETING; HUMAN; MALE; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; NEUROPHYSIOLOGY; NEUROTRANSMISSION; PENILE BLOOD VESSEL; PENIS ERECTION; PROTEIN DEGRADATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; SMOOTH MUSCLE TONE;

EID: 33744776303     PISSN: 18712592     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eeus.2006.03.003     Document Type: Article

References (70)

1. Andersson K.E., and Wagner G. Physiology of penile erection. Physiol Rev 75 (1995) 191-236
2. Andersson K.E. Pharmacology of penile erection. Pharmacol Rev 53 (2001) 417-450
3. Giuliano F., and Rampin O. Neural control of erection. Physiol Behav 83 (2004) 189-201
4. Argiolas A., and Melis M.R. Central control of penile erection: role of the paraventricular nucleus of the hypothalamus. Prog Neurobiol 76 (2005) 1-21
5. Giuliano F. Control of penile erection by the melanocortinergic system: experimental evidences and therapeutic perspectives. J Androl 25 (2004) 683-691
6. Dail W.G., Trujillo D., de la Rosa D., and Walton G. Autonomic innervation of reproductive organs: analysis of the neurons whose axons project in the main penile nerve in the pelvic plexus of the rat. Anat Rec 224 (1989) 94-101
7. Mills T.M., Chitaley K., and Lewis R.W. Vasoconstrictors in erectile physiology. Int J Impot Res 13 (2001) S29-S34
8. Maggi M., Filippi S., Ledda F., Magini A., and Forti G. Erectile dysfunction: from biochemical pharmacology to advances in medical therapy. Eur J Endocrinol 143 (2000) 143-154
9. Traish A.M., Netsuwan N., Daley J., Padman-Nathan H., Goldstein I., and Saenz de Tejada I. A heterogenous population of adrenergic receptors mediates contraction of human corpus cavernosum smooth muscle to norepinephrine. J Urol 153 (1995) 222-227
10. Molderings G.J., Gothert M., van Ahlen H., and Porst H. Noradrenaline release in human corpus cavernosum and its modulation via presynaptic alpha 2-adrenoceptors. Fundam Clin Pharmacol 3 (1989) 497-504
11. Simonsen U., Prieto D., Hernandez M., Saenz de Tejada I., and Garcia-Sacristan A. Prejunctional alpha 2-adrenoceptors inhibit nitrergic neurotransmission in horse penile resistance arteries. J Urol 157 (1997) 2356-2360
12. Filippi S., Luconi M., Granchi S., Natali A., Tozzi P., Forti G., et al. Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation. Int J Impot Res 14 (2002) 295-307
13. Traish A.M., Kimm N.N., Goldstein I., and Moreland R.B. Alpha adrenergic receptors in the penis:identification, characterization and physiological function. J Androl 20 (1999) 671-682
14. Becker A.J., Uckert S., Stief C.G., Truss M.C., Hartmann U., and Jonas U. Systemic and cavernosal plasma levels of endothelin (1-21) during different penile conditions in healthy males and patients with erectile dysfunction. World J Urol 19 (2001) 371-376
15. Saenz de Tejada I., Carson M.P., de las Morenas A., Goldstein I., and Traish A.M. Endothelin: localization, synthesis, activity, and receptor types in human penile corpus cavernosum. Am J Physiol 261 (1991) H1078-H1085
16. Andersson K.E. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol 170 (2003) S6-S14
17. Burnett A.L., Tillman S.L., Chang T.S., Epstein J.I., Lowenstein C.J., Bredt D.S., et al. Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis. J Urol 150 (1993) 73-76
18. Gonzalez-Cadavid N.F., Ignarro L.J., and Rajfer J. Nitric oxide and the cyclic GMP system in the penis. Mol Urol 3 (1999) 51-59
19. Moncada S., Higgs E.A., and Furchgott R.F. International union of pharmacology nomenclature in nitric oxide research. Pharmacol Rev 49 (1997) 137-142
20. Hedlund P., Alm P., and Andersson K.E. NO synthase in cholinergic nerves and NO-induced relaxation in the rat isolated corpus cavernosum. Br J Pharmacol Rev 126 (1999) 349-360
21. Gonzalez-Cadavid N.F., Burnett A.L., Magee T.R., Zeller C.B., Vernet D., Smith N., et al. Expression of penile neuronal nitric oxide synthase variants in the rat and mouse penile nerves. Biol Reprod 63 (2000) 704-714
22. Hurt K.J., Sezen S.F., Champion H.C., Crone J.K., Palese M.A., Huang P.L., et al. Alternatively spliced neuronal nitric oxide synthase mediates penile erection. Proc Natl Acad Sci 103 (2006) 3440-3443
23. Molderings G.J., Gothert M., van Halen H., and Porst H. Modulation of noradrenaline release in human corpus cavernosum by presynaptic prostaglandin receptors. Int J Impot Res 4 (1992) 19-24
24. Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol 155 (1996) 802-815
25. Christ G.J., Moreno A.P., Parker M.E., Gondre C.M., Valcic M., Melman A., et al. Intercellular communication through gap junctions: a potential role in pharmacomechanical coupling and syncytial tissue contraction in vascular smooth muscle isolated from the human corpus cavernosum. Life Sci 49 (1991) PL195-PL200
26. Walsh M.P. The Ayerst Award Lecture 1990. Calcium-dependent mechanisms of regulation of smooth muscle contraction. Biochem Cell Biol 69 (1991) 771-800
27. Burridge K., and Wennerberg K. Rho and Rac take center stage. Cell 116 (2004) 167-179
28. Liming J.N., and Burnett A.L. RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeuthic insight. Clin Sci 110 (2006) 153-165
29. Mills T.M., Lewis R.W., Wingard C.J., Linder A.E., Jin L., and Webb R.C. Vasoconstriction. RhoA/Rho-kinase and the erectile response. Int J Impot Res 15 (2003) S20-S24
30. Chitaley K., Bivalacqua T.J., Champion H.C., Usta M.F., Hellstrom W.J., Mills T.M., et al. Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. Biochem Biophys Res Commun 298 (2002) 427-432
31. Moreland R.B. Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 10 (1998) 113-120
32. Filippi S., Marini M., Vannelli G.B., Crescioli C., Granchi S., Vignozzi L., et al. Effects of hypoxia on endothelin-1 sensitivity in the corpus cavernosum. Mol Hum Reprod 9 (2003) 765-774
33. Carvajal J.A., Germain A.M., Huidobro-Toro J.P., and Weiner C.P. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 184 (2000) 409-420
34. Traish A., Kim N.N., Goldstein I., and Moreland R.B. Cyclic AMP regulates mRNA expression of alpha-1d and alpha-2a adrenergic receptors in cultured human corpus cavernosum smooth muscle cells. Int J Impot Res 12 (2000) S41-S47
35. 1 treatment enhances nitric oxide and erection responses to nerve stimulation in the rat penis by upregulatin constitutive NOS isoforms. J Urol 162 (1999) 2205-2210
36. Angulo J., Cuevas P., Moncada I., Martin-Morales A., Allona A., Fernandez A., et al. Rationale for the combination of PGE1 and S-nitroso glutathione to inuce relaxation of human penile smooth muscle. J Pharmacol Exp Ther 295 (2000) 586-593
37. Gupta S., Moreland R.B., Munarriz R., Daley J., Goldstein I., and Saenz de Tejada I. Possible role of Na+-K+ ATPase in the regulation of human corpus cavernosum. Br J Pharmacol 116 (1995) 2201-2206
38. Christ G.J. K channels as molecular targets for the treatment of erectile dysfunction. J Androl 23 (2002) S10-S19
39. Christ G.J., Day N., Santizo C., Sato Y., Zhao W., Sclafani T., et al. Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo. Am J Physiol-Hearth 287 (2004) 1544-1553
40. Francis S.H., Turko I.V., and Corbin J.D. Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucleic Acid Res Mol Biol 65 (2001) 1-52
41. Mancina R., Filippi S., Marini M., Morelli A., Vignozzi L., Salonia A., et al. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. Mol Hum Reprod 11 (2005) 107-115
42. Loughney K., Hill T.R., Florio V.A., Uher L., Rosman G.J., Wolda S.L., et al. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase. Gene 216 (1998) 139-147
43. Stacey P., Rulten S., Dapling A., and Phillips S.C. Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). Biochem Biophys Res Commun 247 (1998) 249-254
44. Yanaka N., Kotera J., Ohtsuka A., Akatsuka H., Imai Y., Michibata H., et al. Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene. Eur J Biochem 255 (1998) 391-399
45. Lin C.S., Chow S., Lau A., Tu R., and Lue T.F. Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters. Int J Impot Res 14 (2002) 15-24
46. Morelli A., Filippi S., Mancina R., Luconi M., Vignozzi L., Marini M., et al. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 145 (2004) 2253-2263
47. Zhang X.-H., Morelli A., Luconi M., Vignozzi L., Filippi S., Marini M., et al. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol 47 (2005) 409-416
48. Champion H.C., Bivalacqua T.J., Takimoto E., Kaas D.A., and Burnett A.L. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci 102 (2005) 1661-1666
49. Lin G., Xin Z.C., Lue T.F., and Lin C.S. Up and down-regulation of phosphodiesterase-5 as related to tachiphylaxis and priapism. J Urol 170 (2003) S15-S19
50. Vignozzi L., Corona G., Petrone L., Filippi S., Morelli A., Forti G., et al. Testosterone and sexual activity. J Endocrinol Invest 28 (2005) 39-44
51. Morelli A., Filippi S., Zhang X.H., Luconi M., Vignozzi L., Mancina R., et al. Peripheral regulatory mechanisms in erection. Int J Androl 28 (2005) 23-27
52. Heim N., and Hursch C.J. Castration for sex offenders: treatment or punishment? A review and critique of recent European literature. Archiv Sex Behav 8 (1979) 281-304
53. Ellis W.J., and Grayhack J.T. Sexual function in aging males after orchidectomy and estrogen therapy. J Urol 89 (1963) 895-899
54. Rousseau L., Dupont A., Labrie F., and Couture M. Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castration. Archiv Sex Behav 17 (1988) 87-98
55. Traish A.M., and Kim N.N. The physiological role of androgens in penile erection: regulation of corpus cavernosum structure and function. J Sex Med 2 (2005) 759-770
56. Traish A.M., Park K., Dhir V., Kim N.N., Moreland R.B., and Goldstein I. Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 140 (1999) 1861-1868
57. Traish A.M., Munarriz R., O'Connell L., Choi S., Kim S.W., Kim N.N., et al. Effects of medical or surgical castration on erectile function in an animal model. J Androl 24 (2003) 381-387
58. Shen Z.J., Zhou X.L., Lu Y.L., and Chen Z.D. Effect of androgen deprivation on penile ultrastructure. Asian J Androl 5 (2003) 33-36
59. Bhasin S., Taylor W.E., Singh R., Artaza J., Sinha-Hikim I., Jasuja R., et al. The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action. J Gerontol 58 (2003) M1103-M1110
60. Singh R., Artaza J.N., Taylor W.E., Gonzalez-Cadavid N.F., and Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144 (2003) 5081-5088
61. Singh R., Artaza J.N., Taylor W.E., Braga M., Yuan X., Gonzalez-Cadavid N.F., et al. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147 (2006) 141-154
62. Traish A.M., Toselli P., Jeong S.J., and Kim N.N. Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency. J Androl 26 (2005) 242-248
63. Corona G., Mannucci E., Mansani R., Petrone L., Bartolini M., Giommi R., et al. Aging and pathogenesis of erectile dysfunction. Int J Impot Res 16 (2004) 395-402
64. Corona G., Mannucci E., Mansani R., Petrone L., Bartolini M., Giommi R., et al. Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus. Eur Urol 46 (2004) 222-228
65. Shabsigh R. Hypogonadism and erectile dysfunction: the role for testosterone therapy. Int J Impot Res 4 (2003) S9-S13
66. Aversa A., Isidori A.M., Spera G., Lenzi A., and Fabbri A. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol 58 (2003) 632-638
67. Shabsigh R., Kaufman J.M., Steidle C., and Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 172 (2004) 658-663
68. Saenz de Tejada I., Angulo J., Cellek S., Gonzales-Cadavid N., Heaton J., Pickard R., et al. Pathophysiology of erectile dysfunction. J Sex Med 2 (2005) 26-39
69. Vickers M.A., and Satyanarayana R. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Int J Impot Res 14 (2002) 466-471
70. Zhang X.H., Filippi S., Morelli A., Vignozzi L., Luconi M., Donati S., et al. Testosterone Restores Diabetes-Induced Erectile Dysfunction and Sildenafil Responsiveness in Two Distinct Animal Models of Chemical Diabetes. J Sex Med 3 (2006) 253-266